Trials / Unknown
UnknownNCT02960828
"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study
Focal Subthreshold Laser Treatment for Macular Drusen
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.
Detailed description
SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Subthreshold Laser Photocoagulation | Selective Subthreshold Laser Photocoagulation is applied to the periphery of high-risk macular drusen |
| DRUG | intravitreal Anti-VEGF injection | To prevent choroidal neovascularization, intravitreal Anti-VEGF injection is done on a 3 month interval up to 1 year. |
| DEVICE | Subthreshold Laser |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2020-05-01
- Completion
- 2020-12-01
- First posted
- 2016-11-10
- Last updated
- 2019-09-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02960828. Inclusion in this directory is not an endorsement.